GRAIL develops Galleri, a blood test that screens for many types of cancer at once. It last closed at $99.25 on Nov 20, down 5.33% on the day. The next earnings report for GRAL is expected around Mon, Jan 11, 2027. For the quarter ended Sep 2026, GRAL reported EPS of -$2.21 on revenue of $37.5M, with revenue up 3.7% from a year ago. Over its last 8 reports the stock moved an average of 17.2% the session after earnings. Over the last 12 months GRAL insiders bought $0 of stock on the open market and sold $38.3M, according to SEC Form 4 filings.
AI Auto Pilots
Is GRAL in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold GRAL.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on GRALStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
GRAL · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend, nearing oversold
The stock is 28% below its 20 day and 24% below its 50 day average. It is 20% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 36), near oversold. The nearest support is the 100 day average at $98.21, and the nearest resistance the Pivot at $100.52.
Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityHigh, 10.6%/day
Key levels
$166.4752 week high+67.7%
$144.18Swing high (Oct 14)+45.3%
$127.0820 day average+28.0%
$123.3250 day average+24.3%
$102.69Pivot R1+3.5%
$100.52Pivot+1.3%
$99.25Last close
$98.21100 day average−1.0%
$97.09Pivot S1−2.2%
$79.27200 day average−20.1%
$76.60Swing low (Aug 31)−22.8%
$41.5052 week low−58.2%
Indicators
RSI (14)
35.76
Weak, oversold below 30
Neutral
MACD
-6.82
Below its signal line
Bearish
Stochastic
5.8
Near the bottom of its range
Oversold
ADX (14)
27.0
Trending down
Williams %R
-98.1
Oversold below −80, overbought above −20
Oversold
CCI (20)
-123.7
Oversold below −100, overbought above 100
Oversold
Rate of change
−18.3%
Change over 10 sessions
Bearish
ATR (14)
$10.52
Typical daily range, 10.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Above
Rising
Short trendBullish
Long trendNot enough history
MomentumImproving
StretchNormal
VolatilityNormal, 18.6%/day
Key levels
$166.4752 week high+67.7%
$144.18Swing high (Oct 14)+45.3%
$127.0820 day average+28.0%
$123.3250 day average+24.3%
$102.69Pivot R1+3.5%
$100.52Pivot+1.3%
$99.25Last close
$98.21100 day average−1.0%
$97.09Pivot S1−2.2%
$79.27200 day average−20.1%
$76.60Swing low (Aug 31)−22.8%
$41.5052 week low−58.2%
Indicators
RSI (14)
50.89
Middle of its range
Neutral
MACD
14.14
Above its signal line
Bullish
Stochastic
46.4
Middle of its range
Neutral
ADX (14)
35.1
Trending up
Williams %R
-67.6
Oversold below −80, overbought above −20
Neutral
CCI (20)
12.7
Oversold below −100, overbought above 100
Neutral
Rate of change
+30.2%
Change over 10 sessions
Bullish
ATR (14)
$18.47
Typical daily range, 18.6% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Above
MA 200–
What happened before, for GRAL
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how GRAL did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for GRALHow many large options trades hit GRAL, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in GRAL in the last 90 days.
From SEC Form 4 filings by GRAL's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether GRAL is in one of them and how their past GRAL trades turned out.
GRAIL is a healthcare company based in Sunnyvale, California, that develops blood tests for early cancer detection. Its main product, Galleri, screens for many types of cancer from a single blood draw and aims to indicate the organ or tissue where a cancer signal may come from. The company sells Galleri through partnerships with healthcare systems, employers, digital health platforms, payors and life insurance providers. Galleri is not yet approved by the U.S. Food and Drug Administration.